The impact of left ventricular hypertrophy on survival in candidates for liver transplantation

Sachin Batra, Victor I. Machicao, John S. Bynon, Shivang Mehta, Rajasekhar Tanikella, Michael Joseph Krowka, Steven Zacks, James Trotter, Kari E. Roberts, Robert S. Brown, Steven M. Kawut, Michael B. Fallon

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Left ventricular hypertrophy (LVH) occurs in 12% to 30% of patients with cirrhosis; however, its prognostic significance is not well studied. We assessed the association of LVH with survival in patients undergoing a liver transplantation (LT) evaluation. We performed a multicenter cohort study of patients undergoing an evaluation for LT. LVH was defined with transthoracic echocardiography. The outcome of interest was all-cause mortality. LVH was present in 138 of 485 patients (28%). Patients with LVH were older, more likely to be male and African American, and were more likely to have hypertension. Three hundred forty-five patients did not undergo transplantation (212 declined, and 133 were waiting): 36 of 110 patients with LVH (33%) died, whereas 57 of 235 patients without LVH (24%) died (P=0.23). After LT, 8 of 28 patients with LVH (29%) died over the course of 3 years, whereas 9 of 112 patients without LVH (8%) died (P=0.007). This finding was independent of conventional risk factors for LVH, and all deaths for patients with LVH occurred within 9 months of LT. No clinical or demographic characteristics were associated with mortality among LVH patients. In conclusion, the presence of LVH is associated with an early increase in mortality after LT, and this is independent of conventional risk factors for LVH. Further studies are needed to confirm these findings and identify factors associated with mortality after transplantation to improve outcomes.

Original languageEnglish (US)
Pages (from-to)705-712
Number of pages8
JournalLiver Transplantation
Volume20
Issue number6
DOIs
StatePublished - 2014

Fingerprint

Left Ventricular Hypertrophy
Liver Transplantation
Survival
Mortality
Transplantation
African Americans
Multicenter Studies
Echocardiography
Fibrosis
Cohort Studies

ASJC Scopus subject areas

  • Surgery
  • Transplantation
  • Hepatology
  • Medicine(all)

Cite this

Batra, S., Machicao, V. I., Bynon, J. S., Mehta, S., Tanikella, R., Krowka, M. J., ... Fallon, M. B. (2014). The impact of left ventricular hypertrophy on survival in candidates for liver transplantation. Liver Transplantation, 20(6), 705-712. https://doi.org/10.1002/lt.23875

The impact of left ventricular hypertrophy on survival in candidates for liver transplantation. / Batra, Sachin; Machicao, Victor I.; Bynon, John S.; Mehta, Shivang; Tanikella, Rajasekhar; Krowka, Michael Joseph; Zacks, Steven; Trotter, James; Roberts, Kari E.; Brown, Robert S.; Kawut, Steven M.; Fallon, Michael B.

In: Liver Transplantation, Vol. 20, No. 6, 2014, p. 705-712.

Research output: Contribution to journalArticle

Batra, S, Machicao, VI, Bynon, JS, Mehta, S, Tanikella, R, Krowka, MJ, Zacks, S, Trotter, J, Roberts, KE, Brown, RS, Kawut, SM & Fallon, MB 2014, 'The impact of left ventricular hypertrophy on survival in candidates for liver transplantation', Liver Transplantation, vol. 20, no. 6, pp. 705-712. https://doi.org/10.1002/lt.23875
Batra, Sachin ; Machicao, Victor I. ; Bynon, John S. ; Mehta, Shivang ; Tanikella, Rajasekhar ; Krowka, Michael Joseph ; Zacks, Steven ; Trotter, James ; Roberts, Kari E. ; Brown, Robert S. ; Kawut, Steven M. ; Fallon, Michael B. / The impact of left ventricular hypertrophy on survival in candidates for liver transplantation. In: Liver Transplantation. 2014 ; Vol. 20, No. 6. pp. 705-712.
@article{d373fe52188f4e3d9252df216bc5792a,
title = "The impact of left ventricular hypertrophy on survival in candidates for liver transplantation",
abstract = "Left ventricular hypertrophy (LVH) occurs in 12{\%} to 30{\%} of patients with cirrhosis; however, its prognostic significance is not well studied. We assessed the association of LVH with survival in patients undergoing a liver transplantation (LT) evaluation. We performed a multicenter cohort study of patients undergoing an evaluation for LT. LVH was defined with transthoracic echocardiography. The outcome of interest was all-cause mortality. LVH was present in 138 of 485 patients (28{\%}). Patients with LVH were older, more likely to be male and African American, and were more likely to have hypertension. Three hundred forty-five patients did not undergo transplantation (212 declined, and 133 were waiting): 36 of 110 patients with LVH (33{\%}) died, whereas 57 of 235 patients without LVH (24{\%}) died (P=0.23). After LT, 8 of 28 patients with LVH (29{\%}) died over the course of 3 years, whereas 9 of 112 patients without LVH (8{\%}) died (P=0.007). This finding was independent of conventional risk factors for LVH, and all deaths for patients with LVH occurred within 9 months of LT. No clinical or demographic characteristics were associated with mortality among LVH patients. In conclusion, the presence of LVH is associated with an early increase in mortality after LT, and this is independent of conventional risk factors for LVH. Further studies are needed to confirm these findings and identify factors associated with mortality after transplantation to improve outcomes.",
author = "Sachin Batra and Machicao, {Victor I.} and Bynon, {John S.} and Shivang Mehta and Rajasekhar Tanikella and Krowka, {Michael Joseph} and Steven Zacks and James Trotter and Roberts, {Kari E.} and Brown, {Robert S.} and Kawut, {Steven M.} and Fallon, {Michael B.}",
year = "2014",
doi = "10.1002/lt.23875",
language = "English (US)",
volume = "20",
pages = "705--712",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "6",

}

TY - JOUR

T1 - The impact of left ventricular hypertrophy on survival in candidates for liver transplantation

AU - Batra, Sachin

AU - Machicao, Victor I.

AU - Bynon, John S.

AU - Mehta, Shivang

AU - Tanikella, Rajasekhar

AU - Krowka, Michael Joseph

AU - Zacks, Steven

AU - Trotter, James

AU - Roberts, Kari E.

AU - Brown, Robert S.

AU - Kawut, Steven M.

AU - Fallon, Michael B.

PY - 2014

Y1 - 2014

N2 - Left ventricular hypertrophy (LVH) occurs in 12% to 30% of patients with cirrhosis; however, its prognostic significance is not well studied. We assessed the association of LVH with survival in patients undergoing a liver transplantation (LT) evaluation. We performed a multicenter cohort study of patients undergoing an evaluation for LT. LVH was defined with transthoracic echocardiography. The outcome of interest was all-cause mortality. LVH was present in 138 of 485 patients (28%). Patients with LVH were older, more likely to be male and African American, and were more likely to have hypertension. Three hundred forty-five patients did not undergo transplantation (212 declined, and 133 were waiting): 36 of 110 patients with LVH (33%) died, whereas 57 of 235 patients without LVH (24%) died (P=0.23). After LT, 8 of 28 patients with LVH (29%) died over the course of 3 years, whereas 9 of 112 patients without LVH (8%) died (P=0.007). This finding was independent of conventional risk factors for LVH, and all deaths for patients with LVH occurred within 9 months of LT. No clinical or demographic characteristics were associated with mortality among LVH patients. In conclusion, the presence of LVH is associated with an early increase in mortality after LT, and this is independent of conventional risk factors for LVH. Further studies are needed to confirm these findings and identify factors associated with mortality after transplantation to improve outcomes.

AB - Left ventricular hypertrophy (LVH) occurs in 12% to 30% of patients with cirrhosis; however, its prognostic significance is not well studied. We assessed the association of LVH with survival in patients undergoing a liver transplantation (LT) evaluation. We performed a multicenter cohort study of patients undergoing an evaluation for LT. LVH was defined with transthoracic echocardiography. The outcome of interest was all-cause mortality. LVH was present in 138 of 485 patients (28%). Patients with LVH were older, more likely to be male and African American, and were more likely to have hypertension. Three hundred forty-five patients did not undergo transplantation (212 declined, and 133 were waiting): 36 of 110 patients with LVH (33%) died, whereas 57 of 235 patients without LVH (24%) died (P=0.23). After LT, 8 of 28 patients with LVH (29%) died over the course of 3 years, whereas 9 of 112 patients without LVH (8%) died (P=0.007). This finding was independent of conventional risk factors for LVH, and all deaths for patients with LVH occurred within 9 months of LT. No clinical or demographic characteristics were associated with mortality among LVH patients. In conclusion, the presence of LVH is associated with an early increase in mortality after LT, and this is independent of conventional risk factors for LVH. Further studies are needed to confirm these findings and identify factors associated with mortality after transplantation to improve outcomes.

UR - http://www.scopus.com/inward/record.url?scp=84901470917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901470917&partnerID=8YFLogxK

U2 - 10.1002/lt.23875

DO - 10.1002/lt.23875

M3 - Article

C2 - 24659368

AN - SCOPUS:84901470917

VL - 20

SP - 705

EP - 712

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 6

ER -